CAMBRIDGE, Mass., Aug. 9, 2019 /PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today reported financial results for the second quarter ended June 30, 2019."We recently presented positive data from our clinical study of DKN-01 plus KEYTRUDA which

JERUSALEM, Aug. 9, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces financial results for the three and six months ended June 30, 2019.   Highlights of the second quarter 2019 and recent weeks include: Completed the qualifi

CHESTERFIELD, Mo., Aug. 9, 2019 /PRNewswire/ -- Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results for the second quarter of 2019 and announced the formal launch of its RLV line of hemp-extract products at its recent distributor conference in suburban

NEW HAVEN, Conn., Aug. 8, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN, the "Company"), a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological and neuropsychiatric diseases, today reported financial results for the quarter ended June 30, 2019, and prov

SYDNEY, Aug. 9, 2019 /PRNewswire/ -- The iQ Group Global is honoured to be recognised as one of Australia and New Zealand's Top 5 Most Innovative Companies by The Australian Financial Review and BOSS Magazine in its r

SMITHS FALLS, ON, Aug. 9, 2019 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED), (NYSE: CGC) is pleased to announce that it has entered into an agreement to acquire the global cannabinoid-based medical researcher Beckley Canopy Therapeutics ("Beckley Canopy"). The acquisition brings together Canopy's wholly owned research progr

BROOMFIELD, Colo., Aug. 9, 2019 /PRNewswire/ -- A multidisciplinary/interdisciplinary group of orthobiologics experts from the fields of orthopedic surgery, sports medicine, physical medicine and rehabilitation, pain medicine, and interventional spine have embarked on a Delphi panel process to set treatment standards for patients receiving a same day stem cell proce

STOCKHOLM, Aug. 9, 2019 /PRNewswire/ -- OssDsign AB (publ) ("OssDsign" or the "Company"), the Swedish designer and manufacturer of innovative implants for bone regeneration, has filed for a Japanese regulatory approval of OssDsign Cranial. Subsequent to the filing, OssDsign initiates commercial planning for a market entry in Japan.

NEW YORK and SYDNEY, Aug. 9, 2019 /PRNewswire/ -- EnGeneIC Limited, a clinical-stage biopharmaceutical company advancing its pro

NEW YORK, Aug. 8, 2019 /PRNewswire/ -- Bragar Eagel & Squire, P.C. is investigating potential claims against Novartis AG (NASDAQ: NVS) on behalf of Novartis investors. Our investigation concerns whether Novartis has violated the federal securities laws and/or engaged in other unlawful business practices.